Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ZLIXF:US

3.1200 USD 0.1200 4.00%

As of 20:10:01 ET on 12/31/2014.

Snapshot for Zeltia SA (ZLIXF)

Open: 3.1900 Day's Range: 3.1200 - 3.1900 Volume: 80,000
Previous Close: 3.0000 52wk Range: 3.0000 - 3.9500 1-Yr Rtn: -

Stock Chart for ZLIXF

No chart data available.
  • ZLIXF:US 3.1200
  • 1D
  • 1M
  • 1Y
3.0000
Interactive ZLIXF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZLIXF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 30.0434
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.0920
Est. PEG Ratio -
Market Cap (M USD) 693.28
Shares Outstanding (M) 222.20
30 Day Average Volume 2,667
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 07/15/2011
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZLIXF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ZLIXF

Zeltia, S.A. is a holding composed of biotechnological and chemical companies. The Company's main activity is developing marine derived anti-cancer drugs and CNS pathologies treatments. Zeltia's other activities include developing diagnosis kits and RNAi technology based therapeutical applications.

Jose Maria Fernandez Sousa-FaroChairmanPedro Francisco Fernandez PuentesVice Chairman
Maria Luisa De Francia CaballeroChief Financial OfficerFernando Mugarza BorqueDir:Communication
More Company Profile & Key Executives for ZLIXF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil